Skip to main content
Log in

Direct oral anticoagulants reduce costs compared with warfarin

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 US dollars

Reference

  • Datar M, et al. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin. American Journal of Health-System Pharmacy : 29 Jan 2019. Available from: URL: http://doi.org/10.1093/ajhp/zxy032

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Direct oral anticoagulants reduce costs compared with warfarin. PharmacoEcon Outcomes News 822, 5 (2019). https://doi.org/10.1007/s40274-019-5657-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5657-4

Navigation